Adequat dialyse Kvalitetssikring

Slides:



Advertisements
Similar presentations
Hemodialysis Adequacy
Advertisements

A Comparison of Early Versus Late Initiation of Renal Replacement Therapy in Critically III Patients with Acute Kidney Injury: A Systematic Review and.
Nuevas Soluciones en DP, Sirven? Prueba en diabéticos con transporte peritoneal alto y promedio alto Dr. José Ramón Paniagua Sierra Unidad de Investigación.
The Importance of Residual Renal Function Dr Paul Tam June 11, 2010.
MANAGEMENT OF CONTINUOUS HEMODIALYSIS
Measurement and preservation of residual renal function (RRF) in haemodialysis patients Elizabeth Lindley and David Keane Leeds Teaching Hospitals NHS.
EDWARD WELSH MARCH Dialysis Adequacy (?).
The mortality associated with body size and muscle mass, fat mass and abdominal obesity in patients receiving hemodialysis Date: 2012/12/21 實習生:余萍 指導老師:蕭佩珍營養師.
HEMODIALYSIS ADEQUACY HEMODIALYSIS ADEQUACY Laurie Vinci RN, BSN, CNN Laurie Vinci RN, BSN, CNN September 17, 2011 September 17, 2011.
Peritoneal Dialysis Adequacy & Prescription Management
Reference Avram MM, et al. Hemoglobin predicts long-term survival in dialysis patients: a 15-year single-center longitudinal study and a correlation trend.
Anatomy and Physiology of Peritoneal Dialysis
Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.
Peritoneal Dialysis. Source of information neal/
Diseases of the Renal System KNH 413. CKD - Renal Replacement Therapy Hemodialysis (HD) or Peritoneal Dialysis (PD) Type based on underlying kidney disease.
Dose Adjustment in Renal and Hepatic Disease
James Heaf Herlev Hospital University of Copenhagen
Prescription of pediatric peritoneal dialysis
Major Published Clinical Trials in AKI: What do they Really Mean? Michael Zappitelli, MD, MSc Montreal Children's Hospital McGill University Health Centre.
APPLICATION OF INDIVIDUALIZED BAYESIAN UREA KINETIC MODELING TO PEDIATRIC HEMODIALYSIS Olivera Marsenic, Athena Zuppa, Jeffrey S. Barrett, Marc Pfister.
2-4. Estimated Renal Function Estimated GFR = 1.8 x (Cs) x (age) Cockcroft-Gault eq. – Estimated creatine clearance (mL/min) = (140 – age x body weight,
“Adequacy in PD prescription What, How, When?
Renal Physiology and Function Part II Renal Function Tests
Progression of Chronic Kidney Disease
Hemodialysis Adequacy and Monitoring Stuart L. Goldstein, MD Professor of Pediatrics University of Cincinnati College of Medicine Director, Center for.
The balANZ Trial. Source Johnson DW, Clarke M, Wilson V, et al. Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral.
Anemia in CKD The TREAT Trial Reference Pfeiffer MA. A trial of Darbepoetin alpha in type II diabetes and chronic kidney disease. N Engl J Med. 2009;361:2019–2032.
به نام خدا Dialysis Adequacy KT/V and beyond Mohammad Taghi Najafi Assistant Professor of nephrology Tehran University of Medical Science Aug 2016.
Cardiovascular Disease and Antihypertensives The RENAAL Trial Reference Brunner BM, and the RENAAL study group. Effects of losartan on renal and cardiovascular.
신장내과 R4 김효식 /Prof. 전진석 혈액투석의 시작. Dialysis start Patients with eGFR >15 mL/min/1.73 m 2 Generally do not initiate chronic dialysis for such patients, ev.
Diseases of the Renal System
Residual Kidney Function Decline and Mortality
Taking basic physiology to the clinic!
The HEMO Study Hemodialysis (HEMO) Study Reference
Quantification and Dosing of Renal Replacement Therapy in Acute Kidney Injury: A Reappraisal Blood Purif 2017;44: DOI: / Fig.
The ADEMEX Trial Adequacy of PD in Mexico Reference
HEMODIALYSIS ADEQUACY
The IDEAL Study Reference
The CANUSA Trial Reference
Diseases of the Renal System
Diseases of the Renal System
Diseases of the Renal System
PROPPR Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe Trauma. 
Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis  James F. Medcalf, Kevin P.G.
Nephrology Skills Laboratory
A Six-hour Hemodialysis Without a Significant Increase in Dialysis Dose, as Judged by Kt/V, Can Reduce the Dosage of Erythropoietin Department of Kidney.
Volume 64, Pages S3-S12 (December 2003)
Incremental peritoneal dialysis: Effects on the choice of dialysis modality, residual renal function and adequacy  G. Viglino, L. Neri, S. Barbieri  Kidney.
Dialyzer Math.
Volume 88, Issue 2, Pages (August 2015)
Erratum Regarding “Phosphate Removal With Several Thrice-Weekly Dialysis Methods in Overweight Hemodialysis Patients” [Am J Kidney Dis 2009; 54: ] 
Volume 55, Issue 6, Pages (June 1999)
Volume 88, Issue 5, Pages (November 2015)
Health-related quality of life predicts outcomes but is not affected by peritoneal clearance: The ADEMEX trial  Ramon Paniagua, Dante Amato, Edward Vonesh,
Prescribing and monitoring hemodialysis dose
Volume 54, Issue 2, Pages (August 1998)
Peritoneal dialysis adequacy and risk of death
Whither goest Kt/V? Kidney International
Diseases of the Renal System
Urea kinetic analysis of automated peritoneal dialysis allows calculation of a CAPD- equivalent Kt/Vurea  Scott J. Schurman, Lawrence R. Shoemaker, Bradley.
Adult peritoneal dialysis patients
Volume 64, Issue 2, Pages (August 2003)
The following slides highlight a report on a presentation at the American College of Cardiology 2004, Scientific Sessions, in New Orleans, Louisiana on.
Executive summary American Journal of Kidney Diseases
Volume 65, Issue 1, Pages (January 2004)
American Journal of Kidney Diseases 
Dialysis limitations. Dialysis limitations. (A) Recent data from observational studies and randomized, clinical trials indicate significant limitations.
ANZDATA Peritoneal Dialysis Report
Stock and Flow of Peritoneal Dialysis Patients Australia
Stock and Flow of Peritoneal Dialysis Patients Australia
Presentation transcript:

Adequat dialyse Kvalitetssikring K t / V

Hvad er kvalitet…..Effektivitet ?

X Effektivitet =

X Effektivitet =

X Kt/V = Effektivitet = Watson 2.447 - (0.09156 x age) + (0.1074 x height) + (0.3362 x weight)

Kt/V = Din renale

Kt/V = Din renale = 3,6 pr dag . 25 pr uge X 100 ml/min 1440 min

Peritoneal Dialyse Kt/V

+ Kt/V 24 timers opsamling Måling Total dialyse dræn Total Residual urin Total dialyse dræn Måling 10

Målinger Total Urin volumen (liter) u-Carbamid (mmol/l) u-Kreatinin (mmol/l) Total drænmængde(liter) d-Carbamid (mmol/l) d-kreatinin (mmol/l) s-carbamid (mmol/l) s-kreatinin (mmol/l)

Alt kan beregnes med en simpel calculator

K t / V pr uge Kt/V = dialyse Kt/V + renal Kt/V Body Water (watson) Renal carbamid Kt/V: volumen (liter) u-Carb (mmol/l) d-Carb (mmol/l) s-Carb (mmol/l) u-Carbamid s-Carbamid X urin volumen x 7 Body Water (watson) Dialyse carbamid Kt/V: d-Carbamid s-Carbamid x dialysat volumen x 7 Body Water (watson) Kt/V = dialyse Kt/V + renal Kt/V

(Renal clear. + Dialys clear.) x 1,73 m2 Kreatinin Clearance Renal kreatininclearance (GFR): u-kreatinin x volumen + u-carb x volumen volym (liter) u-Urea (mmol/l) u-Kreatinin (mmol/l) d-Urea (mmol/l) d-kreatinin (mmol/l) s-Urea (mmol/l) s-kreatinin (mmol/l) S-kreatinin S-urea 2 Dialyse kreatininclearance: d-kreatinin s-kreatinin x dialysat volumen Om man endast räknar u-kreatinin/s-kreatinin så får man ett falskt högt renalt kreatininclearace då kreatinin inte bara filtreras i glumeruli utan dessutom sekreeras i tubuli Total normaliseret kreatinin clearance: (Renal clear. + Dialys clear.) x 1,73 m2 Patientens BSA 14

Protein Catabolic Rate (nPCR) Calculations Randerson nPCR nPCR = 5.02 * {[Urea Generation Rate (mmol/min) * 60.06] + 3.12} / Weight in kg Bergstrom nPCR nPCR = {19 + (0.213 * Urea Appearance Rate)} / Weight in kg Urea Appearance Rate = {[24 hour Urine(mLs) * Urine Urea (mmol/L)] + [24 hour Drain Volume * Dialysate Urea(mmol/L)]} / 1000

Ideal Body Weight Kun effekt på beregninger af nPCR. Total Body Water og BSA bruger stadig aktuelle vægt.

Målsætning ? Kvalitet og Kt/V

1996: CANUSA : mortality decreased by 6% for each 0 1996: CANUSA : mortality decreased by 6% for each 0.1 u/week increase in weekly Kt/Vurea, and decreased by 7% for each 5L/week/1.73m2 increase in creatinine clearance. 2001: CANUSA reanalysis: (1) PD outcome was predicted by renal Kt/Vurea but not peritoneal Kt/Vurea, (2) changes in survival over time were due to changes in residual renal function, (3) each 5L/week renal GFR was associated with a 12% survival benefit. 2002: ADEMEX: 965 CAPD patients in Mexico   The study achieved a good separation between the two groups (pCcr of 46 vs. 57 L/week/1.73m2). There was no difference in survival at the end of 2 years. Interestingly, the overall mortality rates in this study were similar to the 2 year survival rates seen in the HEMO trial, which evaluated the effect of dialysis dose on outcomes in hemodialysis. 2003: Hong Kong Trial : 320 incident PD patients were randomized to three target pKt/Vurea goals (1.5 - 1.7, 1.7 - 2.0, and > 2.0). This study achieved good separation between the groups, and residual renal function was the same in all groups. There was no difference in survival between the groups; however, the lowest Kt/V group (pKt/Vurea 1.5 - 1.7) exhibited more dropout due to inadequate dialysis, and also require higher doses of ESA to achieve hemoglobin targets.

ISPD GUIDELINES/RECOMMENDATIONS Egen nyrefunktion er godt Residual renal function (measured by renal clearance or urine volume), but not peritoneal clearance, is predictive of survival in prospective observational studies and can account for most of the association between total clearance and survival Mere dialyse ingen effekt Prospective randomized interventional studies do not provide evidence to support a beneficial effect of increasing dialysis to total Kt/V urea above 2.0, or creatinine clearance above 60 L/week/1.73 m2, in patients on continuous ambulatory peritoneal di- alysis (CAPD) with a total Kt/V urea above 1.70 For lidt dialyse ikke godt Interventional studies have demonstrated that total Kt/V below 1.70 is associated with poorer primary or secondary outcome.

Adequacy of dialysis should be interpreted clinically ISPD GUIDELINES/RECOMMENDATIONS Adequacy of dialysis should be interpreted clinically rather than by targeting only solute and fluid removal.

Trivsel Energi Job Ca-P-PTH BT Ødemer Anæmi …….. …….

Målsætning Kvalitet og Kt/V K t / V >= 1.7

d -carbamid = 25 (100 % mætning) bags = 8 - 12 liter/dag Maximum Kt/V 80 kg Water = 40 L se-carbamid = 25 d -carbamid = 25 (100 % mætning) bags = 8 - 12 liter/dag ( D- Carbamid X D-Volumen Ud/ S-Carbamid ) / Body Water poser ialt 8 L : (25 x 8 / 25 ) / 40 = 0,2 day ---> 1,4 weekly poser ialt 12 L : (25 x 12 / 25 ) / 40 = 0,3 day ---> 2,1 weekly

https://www.advancedrenaleducation.com/pd-calculator

Regimen predictions 50 80

Optimization results

Monitor individual patient's clearances over time

The Group Distribution